Ask an Expert: View a Question

Ask an Expert is a free question-and-answer service about breast cancer and breast health that is available on weekends. If you'd like to ask a question or comment, please visit us again on Saturday or Sunday. In the meantime, please search the existing topics using the search tool at the top of the page. It's quite possible that one of our many existing topics already addresses your question.

If you would like a consultation with a breast specialist at the Johns Hopkins Avon Foundation Breast Center, call 443-997-8282. It is possible to get an appointment for a second opinion within a few days of contacting us.

We hope you find the information helpful!.

ForumQuestionsAsk a Question
ADH - Atypical Ductal Hyperplasia
Questions about atypical ductal hyperplasia.
1,082 Ask a Question

AskedPublicly Submitted Question
2/8/2018I was diagnosed with ADH in Sept 2016. I have been on Tamoxifen since then. I want to know the truth. Do I need to take this medication or will monitoring closely have the same outcome? Tamoxifen can reduce the risk of cancer occurring, but won't monitoring to find the cells, locate them and removing them at their earliest stages virtually the same as taking Tamoxifen? I just don't know what the truth is or why would someone not diagnosed with cancer but has ADH have to take such a powerful drug that affects every aspect of my life. In other words, I want to know if taking Tamoxifen is worth all of these side effects that I am experiencing or if progress monitoring by way of MRI and mammogram will find these atypical breast cells with hyperplasia and then have surgery to remove them before they turn cancerous will achieve the same goal: breast cancer prevention? Is Tamoxifen and breast tissue screening not essentially performing the same job to prevent breast cancer from occurring except one has a boat load of life altering side effects for 5 years, and the other for all of 1 hour max?
RepliedJHU's Breast Center Reply
2/9/2018ADH can be a precursor to breast cancer. We surgically remove ADH lesions when they are diagnosed. Treatment with Tamoxifen is to reduce the risk of developing breast cancer in the future, whether you've been diagnosed with breast cancer or not. Many women who are at high risk for developing breast cancer will take Tamoxifen to prevent it. If you can come to us, we will help you make sense of this. Call 443-997-1513.

Please note: This service is not intended to provide primary medical advice concerning specific medical care or treatment. Ask an Expert is a free service operated by health care professionals at the Johns Hopkins Avon Foundation Breast Center. Due to the volume of questions and their complexity, there are times when medical oncologists, surgeons, radiation oncologists or oncology nurses are consulted for their input. These individuals volunteer their time for this service and will respond as soon as they are able. Please do not post or send the same question to us in multiple locations or categories.

The contents of this portion of the website cannot be used as a substitute for a consultation with your doctor or other healthcare provider. It also may not represent the opinions of other Johns Hopkins professionals. It is a free service performed on volunteer time and intended to provide feedback to questions posted by consumers however should not be used as a directive or instructions to now follow. Seeing your own medical provider is always important in getting your needs and questions addressed. In the majority of cases, a clinical examination, review of pathology slides and xrays, along with other medical information is needed to truly provide a consultative service. If you wish to receive a formal consultation with our physicians please call 443-997-8282 for surgical appointments and 410-955-8964 for medical or radiation oncology appts. For breast imaging, call 410-955-4100.


© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System, All rights reserved.